RET and Hashimoto thyroiditis: At the molecular level, upregulation of the RET/RAS/BRAF/ERK/MAPK pathway, which has the capability to induce both a proinflammatory and a protumourigenic thyroid programme, is a possible mechanism linking chronic thyroiditis with carcinogenesis [9].